Brian Nowosielski

Among patients using corticosteroids during hospital stays, researchers assess patient-reported symptoms of long COVID during follow-up.

The collaborative effort includes millions of dollars dedicated to cloud and artificial technology for a global antimicrobial resistance intelligence platform.

With the dual issue of pharmacy deserts and caregiver shortages across the US, technology is filling a much-needed gap for rural patient populations.

Episode 12 explores recent updates from the 2026 ADA Scientific Sessions, highlighting for pharmacists which technologies are making waves in the diabetes space right now.

In part 2 of our interview series with Lisa Lavin, she explored the capabilities of her company’s Home Health Hub and how it’s transforming health care access for rural populations.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Keyerrá Buckley, CPhT, ACPE administrator and technical trainer, Pharmacy Starts.

Across pharmacy type, rurality, and naloxone product type, researchers explore the changes in product availability within North Carolina from 2023 to 2025.

Researchers explore a variety of clinical services in addressing atrial fibrillation, cardiovascular risk, and social determinants of health.

Lisa Lavin, founder, chairman, and CEO of Ōmcare, discusses the Rural Health Innovation Initiative and how collaboration is bringing pharmacy care to rural Minnesota and beyond.

Machine learning can uncover immune responses to conserved pneumococcal protein antigens.

The major retail entity owns and operates pharmacies across many grocery stores, including Giant, Stop & Shop, Food Lion, and more.

Learn about how this functional medicine pharmacist’s personal journey led her to addressing patients’ root causes for disease through exploring gut health dysregulation.

Precedence Research announces a report regarding growth in the market size and trends of controlled substances in the US.

This approval provides pharmacists with an option for patients whose levels remain refractory to lifestyle and standard medication.

A drug already used to protect the kidneys may now offer a broader shield.

The pharmacy profession is evolving, and for some pharmacists, that evolution is leading them far beyond the prescription counter and into the world of functional medicine.

This episode highlights the FDA’s announcement regarding GLP-1 supply stabilization and critical compliance strategies for 503A pharmacies.

Artificial intelligence (AI) is making its way into virtually every corner of the health care industry, and pharmacy benefit managers are no exception.

In a shifting environment, pharmacy success is no longer just about scale but about earning patient trust through consistency and effectively managing affordability.

Tarah Davis, PharmD, MBA, AFMC, discusses the superpower of personalized patient roadmaps and how identifying drug-induced nutrient depletions is the key to resolving digestive dysfunction.

NCPDP joined the Total Pharmacy Solutions Summit event as the keynote session, addressing whether community pharmacy is facing a “Tower Records problem.”

Mike Johnston, CPhT-Adv, CEO of NPTA, detailed how independent pharmacies can transform their staffing from a chronic shortage into a high-performing engine.

The Total Pharmacy Solutions Summit Summer 2026 concluded with a powerful call to action for community pharmacies looking to balance policy, people, and profitability.

Justin Macy, PharmD, JD, and Andrew Funk, PharmD, of NABP, emphasize that compliance is a critical safeguard against the rising threat of counterfeit and illegitimate products.

Pharmacy reimbursement stability is built on transparency, financial visibility, and an understanding of upcoming industry shifts.

Experts explore artificial intelligence in PBM-pharmacy relationships and how the technology may impact sustainability.

Lucas Morgan, Esq, and Dae Lee, PharmD, Esq, CPBS, present on the significant opportunities and regulatory risks surrounding compounded peptides and GLP-1 products in 2026.

Kevin Boesen, PharmD, delivers a session on turning Medicare policy shifts into tangible revenue and workflow efficiency for community pharmacies.

As PBM-pharmacy relationships evolve in real time, staying proactive when a PBM audit comes through could be the difference between thriving and losing essential business.

The pneumococcal vaccine is approved for protection against 21 serotypes in adults over 18 and children between 2 and 17 at high risk of disease.